The step has been taken in line with a decision taken by the COVAX Board in December, 2020

India will soon receive between 190 and 250 million fully subsidised doses of COVID-19 vaccine, a spokesperson of Gavi, a global alliance on vaccines, has confirmed.

He added India would also receive funds up to US $ 30 million for urgent technical assistance and development of cold chain equipment.

“Gavi commits its full support to helping India come through its current crisis. In December 2020, the COVAX Board agreed that India would receive approximately 20 percent of the total doses available to AMC (Advance Market Commitment)- eligible countries through the COVAX Facility - estimated at between 190 and 250 million fully-subsidised doses - subject to vaccine prices and available funds,” a Gavi spokesperson was quoted by an Indian news agency as saying.

“India is also to receive 20 percent of the total funding available to AMC- eligible countries for urgent technical assistance and cold chain equipment, or USD 30 million,” the spokesperson said.

The body has committed its full support to help India in overcoming the crisis caused by the deadly second wave of COVID-19 pandemic.

Gavi, which is leading global efforts to provide vaccines to low and middle-income countries across the globe, further mentioned that considering India has been a producer and supplier of vaccines, the current COVID-19 situation in the country as led to disturbance in its vaccine supply chain.

“Much of COVAX's second quarter supplies were due to be fulfilled by the Serum Institute of India (SII). As the SII focuses production towards domestic needs, this has inevitably led to a shortfall for other parts of the world”, the spokesperson said.

Meanwhile, Gavi also praised the decision taken by the US to make the COVID-19 vaccines easily accessible at the global level, with the help of new mechanisms.

“We also recognise the significance of the (Biden) administration's commitment to work towards increasing raw material production which will have an immediate impact on alleviating current global supply constraints,” the spokesperson said.